Biosignaling is a complex process that involves various pathways through which cells communicate and respond to external signals. Understanding these pathways is crucial for grasping how cells regulate their functions. The three primary types of biosignaling pathways include those utilizing G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and lipid hormones.
The first category, GPCRs, is characterized by receptors that span the cell membrane seven times and interact with heterotrimeric G proteins composed of alpha, beta, and gamma subunits. Two significant GPCR signal transduction pathways are the adenylate cyclase pathway and the phosphoinositide pathway. In the adenylate cyclase pathway, the effector enzyme adenylate cyclase is activated by the stimulatory G protein (GS), leading to the production of cyclic AMP (cAMP), a secondary messenger that activates protein kinase A (PKA). The activation of PKA requires the binding of four cAMP molecules to its regulatory subunits, releasing the active catalytic subunits that initiate cellular responses. Conversely, the inhibitory G protein (GI) can dampen this signaling, with toxins like cholera and pertussis affecting these pathways and leading to diseases characterized by severe symptoms.
In the phosphoinositide pathway, the alpha subunit of the G protein activates phospholipase C, which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into two secondary messengers: diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 promotes calcium release from the endoplasmic reticulum, while DAG activates protein kinase C (PKC) in conjunction with calcium, leading to various cellular responses.
The second category, receptor tyrosine kinases (RTKs), includes receptors that possess intrinsic tyrosine kinase activity, allowing them to phosphorylate tyrosine residues on target proteins. A notable example is the insulin receptor, which activates insulin receptor substrates (IRS) that branch into multiple signaling pathways. One pathway involves phosphoinositide 3-kinase (PI3K), leading to increased glucose uptake and glycogen synthesis, while another pathway involves the RAS-MAPK cascade, which is crucial for cell growth and differentiation.
Lastly, lipid hormones, due to their hydrophobic nature, can easily cross cell membranes and directly influence metabolic processes and gene expression. This direct signaling mechanism allows for rapid cellular responses compared to the more complex pathways involving membrane-bound receptors.
In summary, biosignaling encompasses a variety of pathways that enable cells to respond to their environment, with GPCRs, RTKs, and lipid hormones playing pivotal roles in these processes. Understanding these pathways is essential for comprehending cellular communication and the physiological responses that result from various stimuli.
12. Biosignaling
Summary of Biosignaling
12. Biosignaling
Summary of Biosignaling: Videos & Practice Problems
Topic summary
Summary of Biosignaling centers on three major signaling strategies: GPCRs, receptor tyrosine kinases, and lipid hormone signaling. GPCRs are seven-transmembrane receptors coupled to heterotrimeric G proteins with \(\alpha\), \(\beta\), and \(\gamma\) subunits. In the adenylate cyclase pathway, stimulatory or inhibitory G proteins regulate adenylate cyclase, which produces cAMP; cAMP allosterically activates PKA, and four cAMP molecules are needed to release two active catalytic subunits \(4\\ \text{cAMP} \rightarrow \text{active PKA}\). In the phosphoinositide pathway, phospholipase C cleaves PIP2 into DAG and IP3; IP3 promotes Ca\(^{2+}\) release from the endoplasmic reticulum, and Ca\(^{2+}\) plus DAG activates PKC.
Receptor tyrosine kinases signal through tyrosine phosphorylation, including insulin receptor pathways that branch through IRS1 to regulate glucose metabolism, glycogen synthesis, GLUT4 expression, and growth-related cascades such as RAS and MAPK. The JAK-STAT pathway is a key RTK variation because the receptor lacks a covalently bound tyrosine kinase domain and must recruit JAK before phosphorylation events lead to STAT dimerization and transcriptional control. Lipid hormones act differently: their hydrophobic nature allows diffusion across the plasma membrane, giving them direct effects on metabolism and gene expression.
0
Concept
Summary of Biosignaling
Video duration:
9mSummary of Biosignaling Video Summary
Study Smarter with Worksheets.
Follow along with each video using our printable worksheets
0
Problem
Which of the following statements is FALSE?
A
Activation of the α-adrenergic receptor leads to increased levels of Calcium in the cytoplasm.
B
Cholera toxin causes the inhibition of Gs GTPase activity, leading to an overstimulated signal.
C
Upon receptor autophosphorylation, JAK2 then binds to the receptor via its SH2 homology domains.
D
4 cAMP molecules are required to activate protein kinase A.
E
Phosphorylated and dimerized STAT5 acts as a transcription factor in the nucleus.
Do you want more practice?
More setsSummary of Biosignaling
12. Biosignaling
7 problems
Topic
12. Biosignaling - Part 1 of 5
5 topics 14 problems
Chapter
12. Biosignaling - Part 2 of 5
5 topics 13 problems
Chapter
12. Biosignaling - Part 3 of 5
5 topics 13 problems
Chapter
12. Biosignaling - Part 4 of 5
5 topics 13 problems
Chapter
12. Biosignaling - Part 5 of 5
5 topics 13 problems
Chapter
Go over this topic definitions with flashcards
More setsHere's what students ask on this topic:
Biosignaling pathways primarily include three types: G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and lipid hormone signaling. GPCRs are seven-transmembrane receptors that couple with heterotrimeric G proteins composed of alpha (α), beta (β), and gamma (γ) subunits. They activate secondary messengers like cAMP or IP3/DAG to regulate cellular responses. RTKs have intrinsic tyrosine kinase activity, phosphorylating tyrosine residues to trigger downstream signaling such as insulin pathways and growth factor cascades like RAS/MAPK. The JAK-STAT pathway is a variation where the receptor recruits cytosolic JAK kinase to phosphorylate STAT transcription factors. Lipid hormones, being hydrophobic, diffuse through membranes to directly influence gene expression and metabolism. Each pathway uses distinct mechanisms to convert extracellular signals into cellular actions.
The adenylate cyclase GPCR pathway involves a stimulatory G protein (Gs) activating adenylate cyclase, an effector enzyme that converts ATP into cyclic AMP (cAMP). The increase in cAMP acts as a secondary messenger that allosterically activates protein kinase A (PKA). PKA exists as a heterotetramer with two regulatory and two catalytic subunits. Binding of four cAMP molecules to the regulatory subunits causes the release of two active catalytic subunits, which then phosphorylate target proteins to elicit cellular responses. There is also an inhibitory G protein (Gi) that suppresses adenylate cyclase activity, reducing cAMP levels. This pathway is crucial for regulating processes like metabolism and gene expression.
Phospholipase C (PLC) is the effector enzyme activated by the alpha subunit of a G protein in the phosphoinositide GPCR pathway. PLC cleaves the membrane phospholipid PIP2 (phosphatidylinositol 4,5-bisphosphate) into two secondary messengers: diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 binds to receptors on the endoplasmic reticulum, triggering the release of Ca2+ ions into the cytosol. The increase in Ca2+, together with DAG, activates protein kinase C (PKC), which phosphorylates target proteins to generate cellular responses. This pathway regulates processes such as cell growth, differentiation, and metabolism.
Insulin signaling via RTKs begins when insulin binds to its receptor, which has intrinsic tyrosine kinase activity. This activates the receptor to phosphorylate insulin receptor substrate 1 (IRS1). Phosphorylated IRS1 acts as a docking site for downstream signaling molecules, leading to two main pathways: one involving PI3K (phosphoinositide 3-kinase), PIP3, PDK1, and PKB (Akt), which promotes glucose uptake by increasing GLUT4 expression and glycogen synthesis; and another involving growth factor pathways such as RAS and MAPK, which regulate cell growth and proliferation. These pathways coordinate metabolic and growth responses to insulin.
The JAK-STAT pathway differs from typical RTK signaling because its receptor lacks a covalently bound tyrosine kinase domain. Instead, it recruits a separate cytosolic tyrosine kinase called Janus kinase (JAK). Upon ligand binding, JAK phosphorylates the receptor, creating docking sites for STAT (signal transducer and activator of transcription) transcription factors. Phosphorylated STATs dimerize and translocate to the nucleus to regulate gene expression. This pathway is important in cytokine signaling, such as erythropoietin (EPO) signaling, and controls processes like immune responses and cell growth.
Lipid hormones, such as steroid hormones, differ from GPCR and RTK signaling because they are hydrophobic and can diffuse directly through the plasma membrane. Once inside the cell, they bind to intracellular receptors, often in the cytoplasm or nucleus. These hormone-receptor complexes then act as transcription factors to directly regulate gene expression, leading to changes in metabolism and cellular function. This direct mechanism contrasts with the membrane-bound receptor activation and secondary messenger cascades seen in GPCR and RTK pathways.
